Colin Snow
Placidyl, also known by its generic name ethchlorvynol, was a popular sleeping pill that was manufactured by Abbott Laboratories and on the market since the mid-1950s. It was initially developed by Pfizer and was available in 200 mg, 500 mg, and 750 mg strength gel-filled capsules. Despite its popularity, concerns arose over its potential for abuse and dependence, with warnings against its use beyond one week. In 1999, Abbott discontinued its production due to the rise of alternative medications, such as Librium and Valium. Placidyl's discontinuation highlights the evolving landscape of sleeping pill options and the ongoing pursuit of safe and effective treatments for insomnia and other sleep disorders.
| Characteristics | Values |
|---|---|
| Generic Name | Ethchlorvynol |
| Manufacturer | Abbott Laboratories |
| Marketed From | Mid-1950s |
| Dosage | 200 mg, 500 mg, and 750 mg |
| Usage | Treatment of insomnia |
| Prescription | Required |
| Usage Duration | One week to one month |
| Side Effects | Psychological and physical dependence, allergic reactions |
| Overdose Symptoms | Confusion, severe weakness, shortness of breath, slurred speech, staggering, slow heartbeat |
| Substitute Drugs | Librium, Valium, Zolpidem, Doxepin, Temazepam |
| Status | Discontinued in 1999 |
Explore related products
What You'll Learn
- Placidyl's generic name is ethchlorvynol, a GABA-ergic hypnotic sedative medication
- Abbott Laboratories manufactured Placidyl, which was available in 200, 500, and 750 mg strengths
- Doctors would prescribe Placidyl for extended periods, despite warnings against this
- Placidyl was deemed responsible for the death of Elvis Presley and the hospitalisation of Rehnquist and Steven Tyler
- Placidyl is no longer available, having been discontinued in 1999 due to widespread abuse and safety concerns
Placidyl's generic name is ethchlorvynol, a GABA-ergic hypnotic sedative medication
Placidyl is a sleeping pill that was manufactured by Abbott Laboratories and introduced in the mid-1950s. Its generic name is ethchlorvynol, a GABA-ergic hypnotic sedative medication. Ethchlorvynol was first developed by Pfizer in the 1950s and was sold by Abbott Laboratories under the trade name Placidyl.
Placidyl was available in 200 mg, 500 mg, and 750 mg strength gel-filled capsules. The 500 mg and 750 mg strength capsules were used to reduce sleep latency, while the 200 mg strength capsules were meant to help people fall back asleep if they woke up early. Despite being a popular prescription in the 1970s, Placidyl's popularity declined due to the rise of alternative products and concerns about its effectiveness and safety. By 1977, its use had dropped to an estimated 7% of sleeping prescriptions.
Ethchlorvynol is a potent medication that can be habit-forming and severely physically addictive. It is intended for short-term use, typically ranging from one week to one month. However, doctors often prescribed it for extended periods, which could lead to psychological and physical dependence with prolonged use. In 1979, a study by the National Academy of Sciences' Institute of Medicine raised concerns about Placidyl's risks and benefits, finding it to be less effective than sugar pills in two out of three clinical studies.
Due to the widespread abuse of minor tranquilizers and the emergence of non-barbiturate sedatives like Librium and Valium, Abbott discontinued Placidyl's production in 1999. By the end of 2001, ethchlorvynol reserves in the United States were depleted. While ethchlorvynol could theoretically be manufactured and sold by another company, it faces strict regulations due to its addictive nature and potential for abuse.
Restroom Breaks: Sleep Time Interruptions and Their Normalcy
You may want to see also
Explore related products
Abbott Laboratories manufactured Placidyl, which was available in 200, 500, and 750 mg strengths
Ethchlorvynol, which is sold under the trade name Placidyl, was manufactured by Abbott Laboratories and has been on the market since the mid-1950s. It was originally developed by Pfizer. Abbott Laboratories sold Placidyl in 200 mg, 500 mg, and 750 mg strength gel-filled capsules. The 500 mg and 750 mg strength capsules were used to reduce sleep latency, while the 200 mg strength capsules were intended to help people fall back asleep if they woke up early.
Placidyl was a popular sleeping pill, but its use declined in the 1970s as other products became more common. By 1977, it accounted for an estimated 7% of sleeping pill prescriptions. Despite this, over 1 million prescriptions were filled in 1980, with almost 50% of them being refills.
Placidyl is a GABAA receptor agonist and can be habit-forming and physically addictive. It was indicated for the short-term treatment of insomnia, but doctors often prescribed it for extended periods. In 1999, Abbott Laboratories discontinued production due to the widespread abuse of minor tranquilizers and the rise of non-barbiturate sedatives like Librium and Valium. By the end of 2001, ethchlorvynol reserves in the United States had been depleted.
Today, Placidyl is no longer available, and other medications have taken its place in treating insomnia, such as temazepam, doxepin, and zolpidem.
Should You Wear Sunscreen to Bed?
You may want to see also
Explore related products
$14.95
![GenCare Maximum Strength Nighttime Sleep Aid Supplement for Adults Deep Sleep Pills with Diphenhydramine HCl 50mg to Fall Asleep Faster- Strong Non-Habit Forming PM Sleeping Relief [96 Softgels]](https://m.media-amazon.com/images/I/71WC6IGWvcL._AC_UL320_.jpg)
$21.76 $23.89
Doctors would prescribe Placidyl for extended periods, despite warnings against this
Placidyl, or ethchlorvynol, was a popular sleeping pill that was on the market from the mid-1950s until 1999. It was manufactured by Abbott Laboratories and was available in 200 mg, 500 mg, and 750 mg strength gel-filled capsules. The drug was typically prescribed to treat insomnia or other sleep disorders, and it worked by making patients feel drowsy and relaxed. Despite warnings that Placidyl should only be used for a week at a time, doctors frequently prescribed it for extended periods.
The drug's popularity began to wane in the 1970s as concerns about its safety and effectiveness emerged. A National Institute of Drug Abuse study in 1977 concluded that the use of Placidyl at "current levels is not justifiable." A 1979 study by the National Academy of Sciences' Institute of Medicine also raised questions about the risks and benefits of the drug, finding that it was no better than a sugar pill in two out of three clinical studies and that its effects were weak in two other sleep studies. Despite these concerns, Placidyl remained on the market and was still being prescribed in the 1980s.
The warnings against long-term use of Placidyl were due to its potential for habit-forming and severe physical addiction. Prolonged use of the drug could lead to "psychological and physical dependence," and abrupt cessation could result in potentially lethal withdrawal effects, including convulsions, hallucinations, and amnesia. Additionally, there were concerns about the widespread abuse of minor tranquilizers and non-barbiturate sedatives, which Placidyl fell under. By the end of 2001, ethchlorvynol reserves had dried up in the United States, and Abbott Laboratories discontinued production.
It is worth noting that sleeping pills, in general, are not recommended for long-term use due to the risk of dependence and addiction. They are typically prescribed for short-term relief of sleep disorders and should be used with caution, weighing the risks against the benefits. While Placidyl is no longer available, there are other medications and therapies available to treat insomnia and improve sleep.
Pillows: Sleep's Best Friend or Foe?
You may want to see also
Explore related products
Placidyl was deemed responsible for the death of Elvis Presley and the hospitalisation of Rehnquist and Steven Tyler
Placidyl, also known by its generic name ethchlorvynol, was a popular sleeping pill manufactured by Abbott Laboratories. It was introduced in the mid-1950s and was widely prescribed to treat insomnia. However, concerns arose about its effectiveness and safety. Despite warnings, it was often prescribed for extended periods, leading to cases of addiction and adverse health effects, including hospitalisations and even death.
One notable individual deemed to have been affected by Placidyl was Elvis Presley. On August 16, 1977, Elvis Presley was found dead in Memphis, Tennessee, with a cocktail of drugs in his system, including Placidyl (ethchlorvynol). While the initial assertion was that drugs played no role in his death, later examinations revealed traces of 14 drugs, 10 of which were present in significant amounts. This tragic incident highlighted the dangers of drug abuse and the role of physicians in enabling addiction.
Additionally, Placidyl was implicated in the hospitalisation of William Rehnquist, the Chief Supreme Court Justice, in 1981. Rehnquist underwent a month-long detox for addiction to Placidyl, which he had been taking to aid with insomnia due to a long-term back problem. During his hospitalisation, Rehnquist experienced paranoia, hearing voices plotting against him and exhibiting 'bizarre ideas and outrageous thoughts'. Doctors and drug experts expressed surprise at the prescription of Placidyl for Rehnquist, given its potential for psychological and physical dependence with prolonged use.
Another celebrity affected by Placidyl was Steven Tyler, the frontman of Aerosmith. While Tyler did not require hospitalisation, he struggled with addiction to Placidyl and other substances in the 1980s. He underwent rehab stints during that decade but achieved lasting sobriety through a 12-step program in 2009. Tyler has been candid about his journey, acknowledging that his bandmates' intervention in 1988 played a pivotal role in his recovery.
Due to concerns about its effectiveness and safety, Placidyl's use declined over time. It is no longer available in the US due to dwindling demand, as safer and more effective alternatives have been favoured. However, it can still be found in other countries. Placidyl's legacy underscores the importance of cautious prescription practices and ongoing research into the safety and efficacy of sleeping medications.
Soft Sleep Rollers: The Ultimate Guide
You may want to see also
Explore related products
Placidyl is no longer available, having been discontinued in 1999 due to widespread abuse and safety concerns
The sleeping pill Placidyl, also known as ethchlorvynol, is no longer available, having been discontinued in 1999. This drug was first developed in the 1950s by Pfizer and sold by Abbott Laboratories. It was commonly prescribed to treat insomnia and was available in 200 mg, 500 mg, and 750 mg strength gel-filled capsules.
Despite its popularity, Placidyl was not without its drawbacks. It was deemed a Schedule IV drug under the Controlled Substances Act, which meant it could be refilled up to five times in six months. This contributed to its widespread abuse, as people became psychologically and physically dependent on it. Additionally, it was found to be less effective and more dangerous than other sleeping drugs, with severe side effects and withdrawal symptoms.
In the late 1970s, ethchlorvynol was implicated in the death of Elvis Presley, and Supreme Court Justice William Rehnquist and Steven Tyler of Aerosmith were both hospitalized for detox. These incidents, along with studies raising concerns about the risks and benefits of Placidyl, likely contributed to its discontinuation.
Furthermore, the manufacturer was criticized for not emphasizing the possibility of severe allergic reactions, which resulted in many patients experiencing adverse effects. By the end of 2001, ethchlorvynol reserves had dried up in the United States, and it is now replaced by other medicines for treating insomnia.
While Placidyl may have helped some individuals with their sleep issues, its abuse potential, safety concerns, and the availability of alternative treatments led to its discontinuation.
Monitors Used for Sleep Studies: A Comprehensive Guide
You may want to see also
Frequently asked questions
Placidyl, whose generic name is ethchlorvynol, is a GABA-ergic hypnotic sedative medication first developed by Pfizer in the 1950s. It was sold by Abbott Laboratories in the US under the trade name Placidyl.
Abbott Laboratories discontinued the production of Placidyl in 1999 due to the widespread abuse of minor tranquilizers, and non-barbiturate sedatives largely being replaced by the benzodiazepine family. By the end of 2001, ethchlorvynol reserves had dried up in the United States. Placidyl was also deemed to be less effective and more dangerous than other sleeping drugs, and was found to be habit-forming and physically addictive.
There are many alternatives to Placidyl, including prescription sleeping pills, natural sleep aids, and nondrug therapies. Prescription sleeping pills include antidepressants, barbiturates, and benzodiazepines (benzos). Natural sleep aids include melatonin and valerian root supplements. Nondrug therapies include cognitive behavioral therapy (CBT).
